Mandeep Singh
No mentions found
This entity hasn't been tracked yet, or Iris is still building its knowledge base.
Related Articles from SNS
Broadcom Sinks After Disappointing AI Chip Outlook
Broadcom shares fall in biggest drop since January 2025, after the chipmaker gave an outlook that was seen as underwhelming given the industry’s AI-related demand. Bloomberg's Mandeep Singh joined to discuss.
Fear of recurrence: How immune memory helps cancer survivors face their worst nightmare
Every year the world observes National Cancer Survivors Month in June, celebrating the growing number of people who have successfully completed cancer treatment and are building lives beyond their diagnosis. For many survivors, however, the end of treatment does not always bring complete peace of mind. Even years later, routine scans, follow-up appointments or unexplained aches can revive a lingering question: What if the cancer comes back?
Chemotherapy drug supply crisis hits cancer care
NEW DELHI: Cancer patients across India are scrambling to procure two life-saving chemotherapy drugs as a shortage of Cisplatin and Carboplatin begins to disrupt treatment schedules. Doctors at AIIMS Delhi, private hospitals and cancer centres across the country warn that prolonged shortages could affect outcomes for patients undergoing curative treatment. Hospitals are reporting dwindling stocks, while patients and their families are being forced to hunt for pharmacies and distributors...